Abstract
Crohn's disease and ulcerative colitis are the most common chronic inflammatory bowel diseases. The diagnosis is based on clinical presentation and endoscopic findings completed by histopathology. The therapeutic options range from topical antiinflammatory therapies to classical immunosuppression and biological agents, i. e. anti-TNF-antibodies. This manuscript gives an overview on the state of the art in diagnostics and therapy ofboth, Crohn's disease and ulcerative colitis. Therapeutic algorithms are based on the statements of the German consensus conferences.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
